Provincial differences in infant deaths in South Africa - An effect of antiretroviral interventions?

Southern African Journal of HIV Medicine

Volumn , Issue 39, 2011, Pages 20-23

  Boulle, A ^a   Thompson, M L ^a,b   Laubscher, R ^c   Johnson, L F ^a   Sayed, R ^a   Brody, L L ^a   Draper, B ^a   Cotton, M F ^d   Abdullah, F ^e   Myers, J E ^a   Bourne, D E ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e TUBERCULOSIS AND MALARIA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CHILD DEATH; EPIDEMIC; FEMALE; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT; INFANT MORTALITY; PREGNANT WOMAN; SOUTH AFRICA;

EID: 79957993193     PISSN: 16089693     EISSN: None     Source Type: Journal    
DOI: 10.4102/sajhivmed.v12i1.207     Document Type: Article

References (28)

1. World Health Organization. Towards Universal Access: Scaling up Priority HIV/AIDS in the Health Sector. Progress Report. Geneva: WHO, 2008.
2. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006;296(7):782-793. (Pubitemid 44223102)
3. Boulle A, Bock P, Osler M, et al. Antiretroviral therapy and early mortality in South Africa. Bull World Health Organ 2008;86(9):678-687.
4. Ndirangu J, Newell ML, Tanser F, Herbst AJ, Bland R. Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact? AIDS 2010;24(4):593-602.
5. Herbst AJ, Cooke GS, Barnighausen T, KanyKany A, Tanser F, Newell ML. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ 2009;87(10):754-762.
6. Jahn A, Floyd S, Crampin AC, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 2008;371:1603-1611. (Pubitemid 351626844)
7. Statistics South Africa. Mortality and Causes of Death in South Africa, 2006: Findings from Death Notification. Pretoria: Statistics South Africa, 2008.
8. Bourne DE, Thompson M, Brady LL, et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS 2009;23(1):101-106.
9. Marinda E, Humphrey JH, Iliff PJ, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007;26(6):519-526. (Pubitemid 46847314)
10. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004;364:1236-1243. (Pubitemid 39311344)
11. National Department of Health. 2008 National Antenatal Sentinel HIV & Syphilis Prevalence Survey. Pretoria: Department of Health, 2009.
12. Johnson L. Child health: HIV/AIDS. In: Pendlebury S, Lake L, Smith C, eds. South African Child Gauge 2008/2009. Cape Town: Children's Institute, University of Cape Town, 2009.
13. Darikwa TB. Estimating the level and trends of child mortality in South Africa, 1996-2006. MPhil (Demography) thesis, University of Cape Town, 2009.
14. Abdullah MF, Young T, Bitalo L, Coetzee N, Myers JE. Public health lessons from a pilot programme to reduce mother-to-child transmission of HIV-1 in Khayelitsha. S Afr Med J 2001;91(7):579-583. (Pubitemid 32707860)
15. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999;353:773-780.
16. Western Cape Department of Health. Antenatal HIV and Syphilis Prevalence Survey 2001. Cape Town: Western Cape Department of Health, 2002.
17. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
18. Draper B, Abdullah F. A review of the prevention of mother-to-child transmission programme of the Western Cape provincial government, 2003-2004. S Afr Med J 2008;98(6):431-434.
19. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004;351(3):217-228.
20. Coetzee D, Hilderbrand K, Boulle A, Draper B, Abdullah F, Goemaere E. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull World Health Organ 2005;83(7):489-494.
21. Health Systems Trust. District Health Barometer 2007/08. Durban: Health Systems Trust, 2009.
22. Mayaux MJ, Burgard M, Teglas JP, et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA 1996;275(8):606-610.
23. Yudkin PL, Burger EH, Bradshaw D, Groenewald P, Ward AM, Volmink J. Deaths caused by HIV disease under-reported in South Africa. AIDS 2009;23(12):1600-1602.
24. ASSA2003lite Aids and Demographic Model of the Acturial Society of South Africa. http://www.assa.org.za (accessed 7 May 2009).
25. National Department of Health. The National HIV and Syphilis Prevalence Survey South Africa 2003. Pretoria: Department of Health, 2004.
26. National Department of Health. The National HIV and Syphilis Prevalence Survey South Africa 2005. Pretoria: Department of Health, 2006.
27. National Department of Health. The National HIV and Syphilis Prevalence Survey South Africa 2007. Pretoria: Department of Health, 2008.
28. Johnson L. HIV and health - access to PMTCT: HIV testing. Children count: Statistics on children in South Africa. Cape Town: Children's Institute, University of Cape Town, 2009. http://www.childrencount.ci.org.za (accessed 24 May 2010).